Literature DB >> 32857181

Antinociceptive effects of lead acetate in sciatic nerve chronic constriction injury model of peripheral neuropathy in male Wistar rats.

Bamidele Victor Owoyele1, Ahmed Olalekan Bakare2, Maryam Tayo Ayinla2, Kehinde Ahmed Adeshina2, Damilola Onietan2, Saheed O Azeez2.   

Abstract

The toxicological effects of lead and its compounds have overshadowed its possible health beneficial effects. Currently, the success rate for treating neuropathic pain has been very low. This study investigated the antinociceptive effects of orally administered low dose lead acetate in sciatic nerve ligated Wistar rats. Thirty Wistar rats randomly divided into five groups were used for this study. Chronic constriction injury (CCI) was used to induce neuropathic pain in Wistar rats. Allodynic and hyperalgesic signs were investigated using von Frey filaments and hotplate, respectively. Morris water maze test was used to assess the memory functions of the rats. The study revealed that oral administration of low-dose lead acetate significantly (p < 0.05) increased pain thresholds of ligated rats. CCI enhanced memory function in Wistar rats which was significantly decreased following lead acetate administration. The findings suggest that lead acetate possesses antinociceptive effects in peripherally induced neuropathic pain model in Wistar rats.

Entities:  

Keywords:  Allodynia; Hyperalgesia; Lead acetate; Memory; Neuropathic pain; Sciatic nerve

Year:  2020        PMID: 32857181     DOI: 10.1007/s00210-020-01951-w

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

Review 1.  Pharmacologic management of neuropathic pain: evidence-based recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Miroslav Backonja; John T Farrar; Nanna B Finnerup; Troels S Jensen; Eija A Kalso; John D Loeser; Christine Miaskowski; Turo J Nurmikko; Russell K Portenoy; Andrew S C Rice; Brett R Stacey; Rolf-Detlef Treede; Dennis C Turk; Mark S Wallace
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

2.  The evidence for pharmacological treatment of neuropathic pain.

Authors:  Nanna Brix Finnerup; Søren Hein Sindrup; Troels Staehelin Jensen
Journal:  Pain       Date:  2010-09       Impact factor: 6.961

3.  Effect of acute and chronic lead exposure on apomorpine-induced sniffing in rats.

Authors:  Soheila Fazli-Tabaei; Mohammad Fahim; Mohammad-Reza Zarrindast
Journal:  Pharmacol Toxicol       Date:  2003-02

4.  Chronic lead exposure attenuates ethanol-induced hypoalgesia.

Authors:  R T Burkey; J R Nation; G R Bratton
Journal:  Pharmacol Biochem Behav       Date:  1994-02       Impact factor: 3.533

5.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

Authors:  G J Bennett; Y K Xie
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

6.  Effects of triethyl lead on hot-plate responsiveness and biochemical properties of hippocampus.

Authors:  S C Bondy; J S Hong; H A Tilson; T J Walsh
Journal:  Pharmacol Biochem Behav       Date:  1985-06       Impact factor: 3.533

7.  Chronic trans-astaxanthin treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with chronic pain.

Authors:  Xi Jiang; Qizhi Yan; Fuhe Liu; Changfeng Jing; Lianshu Ding; Lijin Zhang; Cong Pang
Journal:  Neurosci Lett       Date:  2017-10-02       Impact factor: 3.046

8.  Effects of L-cysteine on lead acetate induced neurotoxicity in albino mice.

Authors:  Y I Mahmoud; S S Sayed
Journal:  Biotech Histochem       Date:  2016-04-04       Impact factor: 1.718

9.  Analgesic and anti-inflammatory effects of the methanol root extracts of some selected Nigerian medicinal plants.

Authors:  Ismail O Ishola; Esther O Agbaje; Olufunmilayo O Adeyemi; Rakesh Shukla
Journal:  Pharm Biol       Date:  2014-04-03       Impact factor: 3.503

10.  Neuropathic pain as a process: reversal of chronification in an animal model.

Authors:  Liliane J Dableh; Kiran Yashpal; James L Henry
Journal:  J Pain Res       Date:  2011-09-29       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.